TF-12-radiolabeled IMP-288 (Immunomedics)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTF-12-radiolabeled IMP-288 (Immunomedics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionTumor-associated calcium signal transducer 2 modulators

TargetsTumor-associated calcium signal transducer 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A